Light Chain Deposition Disease (LCDD or MIDD)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Light Chain Deposition Disease (LCDD or MIDD) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT01383759

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone…

The goal of this clinical trial is to determine the toxicity and also the efficacy of a treatment that includes the following treatment: Two medications, bortez…

United States20 participantsStarted 2011-06-24

Treatment: Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone